This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Suzhou Kintor Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Chun Deng in Pharmaceutical Compositions
Introduction
Chun Deng is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on thiohydantoin compounds. His research focuses on the development of amorphous substances and crystals that have potential applications in medicine.
Latest Patents
Chun Deng holds a patent for "Amorphous substances, crystals, pharmaceutical compositions, preparation methods and uses of thiohydantoin compound or pharmaceutically acceptable salt thereof." This invention relates to the creation of amorphous substances and crystals of a thiohydantoin compound, specifically 1,5-naphthalene disulfonate. The patent outlines various pharmaceutical compositions, preparation methods, and potential uses for these compounds, showcasing the innovative nature of his work. He has 1 patent to his name.
Career Highlights
Chun Deng is currently employed at Suzhou Kintor Pharmaceuticals, Inc., where he continues to advance his research in pharmaceutical sciences. His work has contributed to the development of new therapeutic options, enhancing the efficacy of treatments available in the market.
Collaborations
Chun Deng collaborates with Youzhi Tong, a fellow researcher, to further explore the applications of his inventions in the pharmaceutical industry.
Conclusion
Chun Deng's innovative contributions to the field of pharmaceuticals highlight the importance of research and development in creating new medical solutions. His work on thiohydantoin compounds represents a significant advancement in pharmaceutical compositions, paving the way for future discoveries.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile